TeselaGen Stock

TeselaGen is accelerating the design and fabrication of DNA with synthetic biology software.

About TeselaGen Stock

TeselaGen is building a rapid prototyping system for fast bio-based construction of sustainably sourced chemicals, therapeutic medicines, and novel vaccines. Their customers are biopharmaceutical and bioindustrial companies like Amgen and Genomatica. Their bioCAD/CAM system is based on technology exclusively licensed from Lawrence Berkeley National Lab and is being beta tested by hundreds of users.

Management

Founder and Chief Scientific Officer

Nathan Hillson

Founder & CEO

Michael Fero

Founder & CTO

Eduardo Abeliuk

Team Member

Nick Elsbree

Press

TeselaGen Is Building A Platform For Rapid Prototyping in Synthetic Biology

TechCrunch - Mar, 10 2014

Other Companies

Learn More

Axxiome Group

A global financial services software, innovation and advisory company focused on disruption and transformation.

People powered marketing platform

CTRL-Labs dedicates itself to answering the biggest questions in computing, neuroscience, and design so creators can dream.

Fueled by an innovative drive and a deep understanding of the microbiome, Pivot Bio is pioneering game-changing advances in crop nutrition.

10Age (years)

$86.7MTotal Funding

EquityZen does not have an affiliation with, formal relationship with, or endorsement from TeselaGen or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Trending Companies

Join 110K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Why EquityZen?

EquityZen helps investors to access private companies and their employees to sell shares.

Investment opportunities posted on this website are "private placements" of securities that are not publicly traded, are subject to holding period requirements, and are intended for investors who do not need a liquid investment. Investing in private companies may be considered highly speculative and involves a high degree of risk, including the risk of substantial loss of investment. Investors must be able to afford the loss of their entire investment. See our Risk Factors for a more detailed explanation of the risks involved by investing through EquityZen’s platform.

EquityZen Securities LLC (“EquityZen Securities”) is a subsidiary of EquityZen Inc. EquityZen Securities is a broker/dealer registered with the Securities Exchange Commission and is a FINRA/SIPC member firm.

Equity securities are offered through EquityZen Securities. Check the background of this firm on FINRA’s BrokerCheck.

EquityZen.com is a website operated by EquityZen Inc. ("EquityZen"). By accessing this site and any pages thereof, you agree to be bound by our Terms of Use.
EquityZen and logo are trademarks of EquityZen Inc. Other trademarks are property of their respective owners.
© 2020 EquityZen Inc. All rights reserved.